Search

everythinglearnresearchcommunity

for

Search:↓

Behavioral therapies are more effective than drugs for treating trichotillomania.

Mesotherapy is effective for treating certain types of hair loss.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Combining different treatments may be needed to effectively manage chronic prostatitis.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

High-intensity phototechnology, especially with other treatments, effectively improves quality of life for diffuse alopecia patients.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Many transgender men on testosterone therapy experience hair loss.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Combining PRP and minoxidil is more effective for hair loss than using either alone.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Fractional infrared technology is effective and safe for treating cervical laxity.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.